Task: Answer the multiple-choice question.
Question: Which drug exhibits a -25.074\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] Cn1nc(N)c2c(-c3ccc(Cl)cc3)c(C#N)c(N)nc21
[b] Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)N3CCc4ccccc4C3)cc2)o1
[c] C=C(C)[C@@H]1CC=C(CN2CCC(CCOC)(C(=O)OCC)CC2)CC1
[d] CCOc1ccc(NC(=O)CSc2ccc3nnc(-c4cccnc4)n3n2)cc1
[e] COc1ccc([N+](=O)[O-])cc1NC1CCCCC1.O=C(O)C(=O)O
Answer: d. CCOc1ccc(NC(=O)CSc2ccc3nnc(-c4cccnc4)n3n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(NC(=O)CSc2ccc3nnc(-c4cccnc4)n3n2)cc1
CCOc1ccc(NC(=O)CSc2ccc3nnc(-c4cccnc4)n3n2)cc1
N-(4-ethoxyphenyl)-2-[(3-pyridin-3-yl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)sulfanyl]acetamide